E. Coli Vaccine Research Study
E.Coli Vaccine Research Study For Seniors With UTIs
Are you 60 years of age or older?
Help us find a way to prevent bloodstream infections.
People aged 60 years or older, with a history of urinary tract infection (UTI), are at an increased risk of developing a bloodstream infection caused by an E. coli bacteria. Learn more about the E.mbrace Study, a clinical research study to assess the effectiveness and safety of an investigational vaccine in the prevention of bloodstream infection.
You may be eligible to participate in this study if you:
- Are 60 years of age or older
- Have had a UTI in the past 2 years
- Feel comfortable, or have a caregiver who is comfortable, using an application on a smartphone
If you are interested, additional eligibility criteria will be assessed by the study team. The commitment for this study is approximately 3 years.
Qualified participants may receive the investigational vaccine and some study-required medical care at no cost. The study will not pay for other medical care or current medication(s) needed to support your daily health care routine. To learn more about this clinical research study and see if it’s right for you, please contact Tandem Clinical Research using the form below.